Microbix Biosystems Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MBXBF research report →
About the company
Microbix Biosystems Inc. is a life sciences enterprise that invents and markets unique biological and technological innovations designed to improve human health and well-being. Operating across North America, Europe, and other international markets, the company primarily produces essential biological reagents for the diagnostics industry.
- CEO
- Cameron L. Groome
- IPO
- 2021
- Employees
- 100
- HQ
- Mississauga, ON, CA
Price Chart
- Market Cap
- $29.70M
- P/E
- -7.32
- P/S
- 2.78
- P/B
- 1.65
- EV/EBITDA
- -12.93
- Div Yield
- 0.00%
- Gross Margin
- 42.49%
- Op Margin
- -33.32%
- Net Margin
- -38.62%
- ROE
- -21.02%
- ROIC
- -15.19%
- Revenue
- $18.61M · -26.71%
- Net Income
- $-2,248,992 · -163.89%
- EPS
- $-0.02 · -162.79%
- Op Income
- $-1,576,154
- FCF YoY
- -136.00%
- 52W High
- $0.23
- 52W Low
- $0.15
- 50D MA
- $0.19
- 200D MA
- $0.18
- Beta
- 0.57
- Avg Volume
- 7.78K
Get TickerSpark's AI analysis on MBXBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MBXBF coverage
Recent articles, reports, and earnings notes.
No research on MBXBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MBXBF report →Similar companies
Peers in the same neighborhood.